来自3D培养的MSCs的sEV与miR-27b-3p进行工程,用于通过抑制骨干细胞形成来治疗TMJ-OA
Jie Zhou1, Zhiling Zhang2,3, Shuang Fu1
1Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Weijin Road 94th, Tianjin, 300071, P. R. China.
Small (Weinheim an der Bergstrasse, Germany)
|September 29, 2025
概括
工程小细胞外囊泡 (sEV-r) 通过减少炎症和恢复骨平衡,有效治疗关节骨关节炎 (TMJ-OA). 这种新疗法针对巨细胞两极分化和氧化应激来改善关节健康.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 骨关节炎研究 骨关节炎研究
背景情况:
- 关节骨关节炎 (TMJ-OA) 的特征是炎症介导的骨代谢失衡.
- 介酶干细胞衍生的小细胞外囊泡 (sEV) 通过miR-27b-3p/CSF-1轴调节巨细胞极化.
研究的目的:
- 开发功能增强的工程 sEV (sEV-r) 用于TMJ-OA治疗.
- 为了利用3D培养和电穿孔来优化sEV生物活性和miR-27b-3p负载.
主要方法:
- 工程 sEV (sEV-r) 是使用3D动态培养和电穿孔创建的.
- 在体外验证评估了sEV-r抑制CSF-1驱动的炎症和增强骨髓介质干细胞 (BMSC) 迁移的效果.
- 在体内研究评估了急性炎症和TMJ-OA小鼠模型中的sEV-r疗效.
主要成果:
- 通过miR-27b-3p输送,sEV-r有效地抑制了炎症级联.
- 在TMJ-OA模型中,sEV-r调节了巨细胞极化,并抑制了氧化应激.
- 治疗效果包括改善下骨微观结构,恢复骨代谢平衡.
结论:
- sEV-r在TMJ-OA方面显示出卓越的治疗疗效.
- 这项研究提出了基于sEV的向治疗的新型工程策略.
- 结果为TMJ-OA的精确干预提供了关键的见解.
相关概念视频
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K


